Private Equity Portfolio News: Endeavor BioMedicines Closes $101M Series B Financing to Advance Clinical-Stage Precision Medicine Pipeline
Three oncology and fibrotic disease programs in clinical development by end of 2022 SAN DIEGO (BUSINESS WIRE) — Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal…